Skip to menu Skip to content Skip to footer

2010

Journal Article

Using population pharmacokinetics to determine Gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury

Roberts, Jason A., Field, Jonathan, Visser, Adam, Whitbread, Rosemary, Tallot, Mandy, Lipman, Jeffrey and Kirkpatrick, Carl M. J. (2010). Using population pharmacokinetics to determine Gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury. Antimicrobial Agents and Chemotherapy, 54 (9), 3635-3640. doi: 10.1128/AAC.00222-10

Using population pharmacokinetics to determine Gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury

2010

Journal Article

Pharmacokinetics and pharmacodynamics in critically ill patients

Varghese, Julie M., Roberts, Jason A. and Lipman, Jeffrey (2010). Pharmacokinetics and pharmacodynamics in critically ill patients. Current Opinion in Anesthesiology, 23 (4), 472-478. doi: 10.1097/ACO.0b013e328339ef0a

Pharmacokinetics and pharmacodynamics in critically ill patients

2010

Journal Article

Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: Special emphasis on unbound pharmacokinetics

Ulldemolins, Marta, Roberts, Jason A., Wallis, Steven C., Rello, Jordi and Lipman, Jeffrey (2010). Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: Special emphasis on unbound pharmacokinetics. Journal of Antimicrobial Chemotherapy, 65 (8) dkq184, 1771-1778. doi: 10.1093/jac/dkq184

Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: Special emphasis on unbound pharmacokinetics

2010

Journal Article

Pharmacokinetic evaluation of piperacillin-tazobactam

Hayashi, Yoshiro, Roberts, Jason A., Paterson, David L. and Lipman, Jeffrey (2010). Pharmacokinetic evaluation of piperacillin-tazobactam. Expert Opinion on Drug Metabolism and Toxicology, 6 (8), 1017-1031. doi: 10.1517/17425255.2010.506187

Pharmacokinetic evaluation of piperacillin-tazobactam

2010

Journal Article

Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltration

Bilgrami, I., Roberts, J. A., Wallis, S. C., Thomas, J., Davis, J., Fowler, S., Goldrick, P. B. and Lipman, J. (2010). Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltration. Antimicrobial Agents and Chemotherapy, 54 (7), 2974-2978. doi: 10.1128/AAC.01582-09

Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltration

2010

Journal Article

Analysis of 12 beta-lactam antibiotics in human plasma by HPLC with ultraviolet detection

McWhinney, Brett C., Wallis, Steven C., Hillister, Tara, Roberts, Jason A., Lipman, Jeffrey and Ungerer, Jacobus P.J. (2010). Analysis of 12 beta-lactam antibiotics in human plasma by HPLC with ultraviolet detection. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 878 (22), 2039-2043. doi: 10.1016/j.jchromb.2010.05.027

Analysis of 12 beta-lactam antibiotics in human plasma by HPLC with ultraviolet detection

2010

Journal Article

Optimizing antibiotic use in the intensive care unit

Ulldemolins, Marta, Roberts, Jason A. and Lipman, Jeffrey (2010). Optimizing antibiotic use in the intensive care unit. Clinical Pulmonary Medicine, 17 (4), 162-169. doi: 10.1097/CPM.0b013e3181e47953

Optimizing antibiotic use in the intensive care unit

2010

Journal Article

Augmented renal clearance in the Intensive Care Unit: An illustrative case series

Udy, Andrew A., Putt, Michael T., Shanmugathasan, Sulochana, Roberts, Jason A. and Lipman, Jeffrey (2010). Augmented renal clearance in the Intensive Care Unit: An illustrative case series. International Journal of Antimicrobial Agents, 35 (6), 606-608. doi: 10.1016/j.ijantimicag.2010.02.013

Augmented renal clearance in the Intensive Care Unit: An illustrative case series

2010

Journal Article

Meropenem: Focus on its use in serious bacterial infections

Roberts, Jason A., Ulldemolins, Marta and Lipman, Jeffrey (2010). Meropenem: Focus on its use in serious bacterial infections. Clinical Medicine Reviews in Therapeutics, 2, 1-14. doi: 10.4137/CMRT.S4598

Meropenem: Focus on its use in serious bacterial infections

2010

Journal Article

Therapeutic drug monitoring of beta-lactams for critically ill patients: Unwarranted or essential?

Roberts, Jason A., Hope, William W. and Lipman, Jeffrey (2010). Therapeutic drug monitoring of beta-lactams for critically ill patients: Unwarranted or essential?. International Journal of Antimicrobial Agents, 35 (5), 419-420. doi: 10.1016/j.ijantimicag.2010.01.022

Therapeutic drug monitoring of beta-lactams for critically ill patients: Unwarranted or essential?

2010

Journal Article

First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis

Roberts, Jason A., Kirkpatrick, Carl M. J., Roberts, Michael S., Dalley, Andrew J. and Lipman, Jeffrey (2010). First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis. International Journal of Antimicrobial Agents, 35 (2), 156-163. doi: 10.1016/j.ijantimicag.2009.10.008

First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis

2010

Journal Article

Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

Martin, Jennifer H., Norris, Ross, Barras, Michael, Roberts, Jason, Morris, Ray, Doogue, Matthew and Jones, Graham R. D. (2010). Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Clinical Biochemist Reviews, 31 (1), 21-24.

Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

2010

Journal Article

Augmented renal clearance: Implications for antibacterial dosing in the critically Ill

Udy, Andrew A., Roberts, Jason A., Boots, Robert J., Paterson, David L. and Lipman, Jeffrey (2010). Augmented renal clearance: Implications for antibacterial dosing in the critically Ill. Clinical Pharmacokinetics, 49 (1), 1-16. doi: 10.2165/11318140-000000000-00000

Augmented renal clearance: Implications for antibacterial dosing in the critically Ill

2009

Journal Article

Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study

Ranganathan, Dwarakanathan, Varghese, Julie M., Fassett, Robert G., Lipman, Jeffrey, D'Intini, Vincent, Healy, Helen and Roberts, Jason A. (2009). Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study. BMC Nephrology, 10 (1) 42, 1-6. doi: 10.1186/1471-2369-10-42

Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study

2009

Journal Article

Clearance of intravenous 5-fluorocytosine during continuous venovenous haemodiafiltration in a patient with hepatosplenic candidiasis

Roberts, Jason A., Udy, Andrew A., O'Donoghue, Stephen, Briscoe, Scott, Paterson, David L. and Lipman, Jeffrey (2009). Clearance of intravenous 5-fluorocytosine during continuous venovenous haemodiafiltration in a patient with hepatosplenic candidiasis. International Journal of Antimicrobial Agents, 34 (4), 383-384. doi: 10.1016/j.ijantimicag.2009.05.005

Clearance of intravenous 5-fluorocytosine during continuous venovenous haemodiafiltration in a patient with hepatosplenic candidiasis

2009

Journal Article

Tissue Distribution of Beta-Lactam Antibiotics: Continuous versus Bolus Dosing

Roberts, JA and Lipman, J (2009). Tissue Distribution of Beta-Lactam Antibiotics: Continuous versus Bolus Dosing. Journal of Pharmacy Practice and Research, 39 (3), 219-222. doi: 10.1002/j.2055-2335.2009.tb00457.x

Tissue Distribution of Beta-Lactam Antibiotics: Continuous versus Bolus Dosing

2009

Journal Article

Midazolam metabolism: Implications for individualised dosing?

Roberts, Jason A., Coulthard, Mark G., Addison, Russell S., Foot, Carole and Lipman, Jeffrey (2009). Midazolam metabolism: Implications for individualised dosing?. Journal of Pharmacy Practice and Research, 39 (3), 198-201. doi: 10.1002/j.2055-2335.2009.tb00452.x

Midazolam metabolism: Implications for individualised dosing?

2009

Journal Article

Dose matters: Dose of antibiotics in the critically ill patient depends on the dose of renal replacement therapy

Roberts, Jason A. and Lipman, Jeffrey (2009). Dose matters: Dose of antibiotics in the critically ill patient depends on the dose of renal replacement therapy. Critical Care Medicine, 37 (8), 2491-2492. doi: 10.1097/CCM.0b013e3181aee840

Dose matters: Dose of antibiotics in the critically ill patient depends on the dose of renal replacement therapy

2009

Journal Article

A systematic review on clinical benefits of continuous administration of [beta]-lactam antibiotics

Roberts, Jason A., Webb, Steven, Paterson, David, Ho, Kwok M. and Lipman, Jeffrey (2009). A systematic review on clinical benefits of continuous administration of [beta]-lactam antibiotics. Critical Care Medicine, 37 (6), 2071-2078. doi: 10.1097/CCM.0b013e3181a0054d

A systematic review on clinical benefits of continuous administration of [beta]-lactam antibiotics

2009

Journal Article

Pharmacokinetic issues for antibiotics in the critically ill patient

Roberts, Jason A. and Lipman, Jeffrey (2009). Pharmacokinetic issues for antibiotics in the critically ill patient. Critical Care Medicine, 37 (3), 840-851. doi: 10.1097/CCM.0b013e3181961bff

Pharmacokinetic issues for antibiotics in the critically ill patient